Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 926 | 964 | 1293 | 1928 | 3619 | - |
Fund Return | -7.39% | -3.6% | 29.34% | 24.46% | 29.34% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICICI Focused Bluechip Equity RetGr | 632.64B | -1.22 | 15.82 | 12.93 | ||
ICICI Focused Bluechip Eq RetailDiv | 632.64B | -9.39 | 12.01 | 11.25 | ||
ICICI Prud Focused Bluechip Div | 632.64B | -5.49 | 14.62 | 12.95 | ||
ICICI Prud Focused Bluechip Gr | 632.64B | -1.18 | 16.52 | 13.78 | ||
ICICI Balanced Adv Dir Div | 604.34B | -0.18 | 12.00 | 11.14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 89.15B | -8.87 | 18.80 | 13.94 | ||
Reliance Pharma Dividend Payout | 89.15B | -8.87 | 20.21 | 14.98 | ||
Reliance Pharma Fund - Growth | 89.15B | -8.87 | 18.80 | 13.94 | ||
Reliance Pharma Direct Bonus | 89.15B | -8.80 | 19.87 | 14.95 | ||
Reliance Pharma Direct Growth | 89.15B | -8.80 | 19.87 | 14.95 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.83 | 1,749.80 | +0.45% | |
Cipla | INE059A01026 | 9.28 | 1,472.25 | +0.05% | |
Dr Reddy’s Laboratories | INE089A01031 | 8.93 | 1,240.40 | +0.30% | |
Divi's Labs | INE361B01024 | 5.56 | 6,140.55 | +0.34% | |
Aurobindo Pharma | INE406A01037 | 5.05 | 1,191.70 | -0.01% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | Strong Sell | BUY |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review